Pages that link to "Q131140129"
Jump to navigation
Jump to search
The following pages link to Leopoldo Luistro (Q131140129):
Displaying 11 items.
- Discovery of siRNA lipid nanoparticles to transfect suspension leukemia cells and provide in vivo delivery capability (Q39100525) (← links)
- RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response (Q39105611) (← links)
- Gene expression analysis in biomarker research and early drug development using function tested reverse transcription quantitative real-time PCR assays (Q39314544) (← links)
- High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ‐secretase inhibitor, RO4929097 (Q39593637) (← links)
- Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties (Q39796383) (← links)
- In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials (Q40205294) (← links)
- Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment (Q96126104) (← links)
- Teclistamab is an active T cell-redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma (Q99589579) (← links)
- Development of a CD123xCD3 Bispecific Antibody (JNJ-63709178) for the Treatment of Acute Myeloid Leukemia (AML) (Q127076658) (← links)
- The Impact of the Bone Marrow Microenvironment on T Cell Redirection Therapeutics (Q127082739) (← links)
- Abstract 2179: Antitumor activity of JNJ-63576253 (TRC253), a small molecule antagonist of F877L mutant and wild-type androgen receptor (Q127397870) (← links)